玫瑰红孟加拉光动力疗法治疗真菌与棘阿米巴角膜炎的双盲假对照试验:玫瑰红孟加拉绿光电磁激活减少感染研究(REAGIR)
本研究为国际、随机、假对照与安慰剂对照的两臂临床试验,将涂片阳性真菌与棘阿米巴及涂片阴性角膜溃疡患者按1:1随机分配至局部抗菌药物联合假玫瑰红孟加拉光动力疗法组或联合玫瑰红孟加拉光动力疗法组。研究预期玫瑰红孟加拉光动力疗法将改善最佳眼镜矫正视力并减少角膜穿孔及治疗性穿透性角膜移植等并发症。试验注册于NCT(NCT05110001),注册日期2021年11月5日。
要点
- 国际随机双盲假对照两臂试验,比较局部抗菌药物联合玫瑰红孟加拉光动力疗法与联合假疗法。
- 纳入涂片阳性真菌与棘阿米巴及涂片阴性角膜溃疡患者,按1:1随机分组。
- 预期玫瑰红孟加拉光动力疗法改善最佳眼镜矫正视力并减少角膜穿孔与治疗性穿透性角膜移植。
核心结论
- 作者预期玫瑰红孟加拉光动力疗法将改善最佳眼镜矫正视力并减少角膜穿孔及治疗性穿透性角膜移植等并发症。
研究设计与样本
- 国际、随机、假对照与安慰剂对照的两臂临床试验。
- 将涂片阳性真菌与棘阿米巴及涂片阴性角膜溃疡患者按1:1随机分配至局部抗菌药物联合假玫瑰红孟加拉光动力疗法组或联合玫瑰红孟加拉光动力疗法组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infectious keratitis secondary to fungus or acanthamoeba often has a poor outcome despite receiving the best available medical therapy. In vitro rose bengal photodynamic therapy (RB-PDT) appears to be effective against fungal and acanthamoeba isolates (Atalay HT et al., Curr Eye Res 43:1322-5, 2018, Arboleda A et al. Am J Ophthalmol 158:64-70, 2014). In one published series, RB-PDT reduced the need for therapeutic penetrating keratoplasty in severe bacterial, fungal, and acanthamoeba keratitis not responsive to medical therapy. METHODS: This international, randomized, sham and placebo controlled 2-arm clinical trial randomizes patients with smear positive fungal and acanthamoeba and smear negative corneal ulcers in a 1:1 fashion to one of two treatment arms: 1) topical antimicrobial plus sham RB-PDT or 2) topical antimicrobial plus RB-PDT. DISCUSSION: We anticipate that RB-PDT will improve best spectacle-corrected visual acuity and also reduce complications such as corneal perforation and the need for therapeutic penetrating keratoplasty. This study will comply with the NIH Data Sharing Policy and Policy on the Dissemination of NIH-Funded Clinical Trial Information and the Clinical Trials Registration and Results Information Submission rule. Our results will be disseminated via ClinicalTrials.gov website, meetings, and journal publications. Our data will also be available upon reasonable request. TRIAL REGISTRATION: NCT, NCT05110001 , Registered on November 5, 2021.
引用
- Prajna NV, Lalitha P, Sharma S, et al. A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthamoeba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) study. Trials. 2024. PMID: 39192339. doi:10.1186/s13063-024-08376-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。